Including Racial/Ethnic Minorities, Females, Older Adults in Vaccine Trials

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, FEBRUARY 19, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.37640?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=021921

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

What The Study Did: Using data from completed interventional vaccine trials from 2011 to 2020, researchers examined whether racial/ethnic minority groups, females and older adults were underrepresented in U.S.-based vaccine clinical trials.

Authors: Steven A. Pergam, M.D., M.P.H., of the Fred Hutchinson Cancer Research Center in Seattle, and Julie K. Silver, M.D., of Harvard Medical School in Boston, are the corresponding authors.

 

(doi:10.1001/jamanetworkopen.2020.37640)

Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.